1. Home
  2. EBMT vs TTRX Comparison

EBMT vs TTRX Comparison

Compare EBMT & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Bancorp Montana Inc.

EBMT

Eagle Bancorp Montana Inc.

HOLD

Current Price

$23.36

Market Cap

182.5M

Sector

Finance

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$9.62

Market Cap

174.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBMT
TTRX
Founded
1922
2015
Country
United States
United States
Employees
N/A
2
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.5M
174.9M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
EBMT
TTRX
Price
$23.36
$9.62
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$24.00
$8.00
AVG Volume (30 Days)
100.3K
86.0K
Earning Date
04-28-2026
05-31-2026
Dividend Yield
2.55%
N/A
EPS Growth
53.23
N/A
EPS
0.51
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.00
N/A
P/E Ratio
$45.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.50
$2.57
52 Week High
$24.66
$11.69

Technical Indicators

Market Signals
Indicator
EBMT
TTRX
Relative Strength Index (RSI) 51.17 72.73
Support Level $21.59 $4.40
Resistance Level $24.10 N/A
Average True Range (ATR) 0.75 0.99
MACD -0.09 0.24
Stochastic Oscillator 22.78 63.82

Price Performance

Historical Comparison
EBMT
TTRX

About EBMT Eagle Bancorp Montana Inc.

Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: